Summary
- Current Price
- As of today, EVLO price is $0.00, unchanged in the most recent trading session on
- Current Price All-Time High
- EVLO price is currently -100.00% below its historical high of $398.57 set on
- Market Cap
- EVLO current market cap is $1,898, down -80.00% year-over-year
- PE Ratio
- EVLO PE ratio is unknown
- Revenue
- EVLO current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for EVLO has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Evelo Biosciences, Inc. |
| Ticker | NASDAQ: EVLO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | evelobio.com |
| Employees | 66 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| Price, 1D Change | 0.00% | |
| $1,898 | ||
| - | ||
| - | ||
| 1.58 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$26.28 | ||
| EPS, 1Y Change | +43.10% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$26.28 | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $0.00 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | N/A | - | |
| -$1.85 | N/A | - |
Revenue
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -80.00% | ||
| -100.00% | ||
| -80.00% | ||
| -100.00% | ||
| 0.00% | ||
| 0.00% | ||
| +43.10% | ||
| +50.76% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| $0.00 | ||
| SMA 200 vs Price | +300.00% | |
| $0.00 | ||
| SMA 50 vs Price | +200.00% | |
| 1.58 | ||
| $0.00 | ||
| 50.00 | ||
| 251.00% | ||
| 753.10% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$26.28 | ||
| -$4.96M | ||
| - | ||
| -$108.47M | ||
| - | ||
| -$114.53M | ||
| - | ||
| -$106.87M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -10.24 | ||
| 4.16 | ||
| 4.16 | ||
| - | ||
| - | ||
| -16.35 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 0.00 | ||
| -0.22 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$4.99M | ||
| $47.94M | ||
| $64.44M | ||
| $51.57M | ||
| $69.43M | ||
| $12.40M | ||
| $51.14M | ||
| $2.26M | ||
| $1.76M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $108.47M | ||
| $108.47M | ||
| $4.96M | ||
| $29.91M | ||
| $2.06M | ||
| $0.00 | ||
| $930.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$101.24M | ||
| -$622.00K | ||
| $81.66M | ||
| $622.00K | ||
| -$101.86M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| TD Cowen | → | |
| Morgan Stanley | → | |
| Morgan Stanley | ||
| Chardan Capital | → | |
| Morgan Stanley | ||
| Morgan Stanley | ||
| Chardan Capital | ||
| JMP Securities | ||
| Chardan Capital | → | |
| JMP Securities |
Analyst sentiment
Institutional ownership
Screeners with EVLO
FAQ
What is the ticker symbol for Evelo Biosciences, Inc.?
The ticker symbol for Evelo Biosciences, Inc. is NASDAQ:EVLO
Does Evelo Biosciences, Inc. pay dividends?
No, Evelo Biosciences, Inc. does not pay dividends
What sector is Evelo Biosciences, Inc. in?
Evelo Biosciences, Inc. is in the Healthcare sector
What industry is Evelo Biosciences, Inc. in?
Evelo Biosciences, Inc. is in the Biotechnology industry
What country is Evelo Biosciences, Inc. based in?
Evelo Biosciences, Inc. is headquartered in United States
When did Evelo Biosciences, Inc. go public?
Evelo Biosciences, Inc. initial public offering (IPO) was on May 8, 2018
Is Evelo Biosciences, Inc. in the S&P 500?
No, Evelo Biosciences, Inc. is not included in the S&P 500 index
Is Evelo Biosciences, Inc. in the NASDAQ 100?
No, Evelo Biosciences, Inc. is not included in the NASDAQ 100 index
Is Evelo Biosciences, Inc. in the Dow Jones?
No, Evelo Biosciences, Inc. is not included in the Dow Jones index
When was Evelo Biosciences, Inc. last earnings report?
Evelo Biosciences, Inc.'s most recent earnings report was on March 14, 2024
When does Evelo Biosciences, Inc. report earnings?
The date for Evelo Biosciences, Inc.'s next earnings report has not been announced yet
Data Sources & References
- EVLO Official Website www.evelobio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1694665/000169466523000182/0001694665-23-000182-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1694665/000169466523000024/0001694665-23-000024-index.htm
- EVLO Profile on Yahoo Finance finance.yahoo.com/quote/EVLO
- EVLO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/evlo
